PEPTIDE CORTEXThe library
← The library

Wolverine

BPC-157 + TB-500 blendHealing/Recovery
Evidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
1
Read first · not dosing instructions

Educational and research reference only. Not medical advice, not a recommendation, and not dosing instructions for any person. Figures are reported from the cited source and may be wrong or out of date. Research peptides are not approved for human use. Adults 18+. Consult a licensed physician before any decision about your health.

PurposeRecovery blend (BPC-157 + TB-500)
MechanismPre-mixed blend of BPC-157 and TB-500 in one vial. Each component is a separate research compound; the combination itself has not been studied as a product.
EffectsWhat the components are individually studied for: BPC-157 — Healing / Recovery; TB-500 — Healing / Recovery. Read each component’s own entry for its evidence.
DosingNo human dose established.
Bottom lineA vendor-defined combination: no trial has tested the blend, and its evidence is no stronger than its weakest component.
Protocols · as published1 sourced
Community protocol — not clinically establishedCommunity guide
RouteSubcutaneous
FrequencyPre-blend: daily. Separate vials: BPC-157 daily + TB-500 twice weekly.
StartingPre-blend: 1.0 mg total blend daily (500 mcg each)
EscalationNot stated for the pre-blend. Separate-vial loading: BPC-157 250-500 mcg daily + TB-500 2.0-5.0 mg twice weekly.
TargetSeparate-vial maintenance: BPC-157 250 mcg daily + TB-500 2.0 mg 1-2x/week
Cycle6-12 weeks total, often loading + maintenance

Vial sizes vary (10 mg = 5 + 5, 20 mg = 10 + 10); read the composition off the vial. No trial has tested the blend.

Batches on filenone

No tested batches on file.

Read with2
Cautions & interactions

Research-grade blend; not FDA-approved. It carries the cautions of every component — read each one’s entry. Injection-site reactions possible; discuss with a clinician, especially if on anticoagulants or immunosuppressants.

No interaction data for the blend. Each component’s interaction notes apply; avoid combining multiple research compounds without a clinician.

CV 1 of 5 — No cardiovascular outcomes data for the blend; see each component.